Información de Cryoport Inc, dividendo de Cryoport Inc, actividades de los accionistas y más

Más Datos de Cryoport Inc Compañía

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

Información de la empresa

Símbolo de cotizaciónCYRX

Nombre de la empresaCryoport Inc

Fecha de salida a bolsaJul 24, 2015

Fundada en1990

Director ejecutivoMr. Jerrell Wilson (Jerry) Shelton

Número de empleados1090

Tipo de seguridadOrdinary Share

Fin del año fiscalJul 24

Dirección112 Westwood Place, Suite 350

CiudadBRENTWOOD

Bolsa de valoresNASDAQ Capital Market Consolidated

PaísUnited States of America

Código postal37027

Teléfono19492321900

Sitio Webhttps://www.cryoport.com/

Símbolo de cotizaciónCYRX

Fecha de salida a bolsaJul 24, 2015

Fundada en1990

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Jerrell Wilson (Jerry) Shelton

Chairman of the Board, President, Chief Executive Officer

800.92K

+14.27%

Mr. Daniel M. (Dan) Hancock

Independent Director

45.86K

+102.52%

Ms. Linda Baddour

Independent Director

44.90K

+107.03%

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Independent Director

18.43K

+138.85%

Mr. Mark Sawicki

Senior Vice President, Chief Scientific Officer

--

Dr. Ramkumar Mandalam, Ph.D.

Independent Director

--

Mr. Robert S. Stefanovich

Chief Financial Officer, Senior Vice President, Chief Administrative Officer

--

Mr. Ram M. Jagannath

Independent Director

--

Mr. Scott Eckstein

Investor Relations

--

Mr. Edward J. Zecchini

Senior Vice President, Chief Digital and Technology Officer

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Jerrell Wilson (Jerry) Shelton

Chairman of the Board, President, Chief Executive Officer

800.92K

+14.27%

Mr. Daniel M. (Dan) Hancock

Independent Director

45.86K

+102.52%

Ms. Linda Baddour

Independent Director

44.90K

+107.03%

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Independent Director

18.43K

+138.85%

Mr. Mark Sawicki

Senior Vice President, Chief Scientific Officer

--

Dr. Ramkumar Mandalam, Ph.D.

Independent Director

--

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

BioLogistics solutions

138.63M

60.70%

Life Science products

74.72M

32.72%

BioStorage/Bioservices

15.03M

6.58%

Por regiónUSD

Nombre

Ganancia

Proporción

Americas

126.37M

55.33%

Europe & Middle East & Africa (EMEA)

59.60M

26.09%

Asia Pacific

42.42M

18.57%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

BioLogistics solutions

138.63M

60.70%

Life Science products

74.72M

32.72%

BioStorage/Bioservices

15.03M

6.58%

Estadísticas de accionistas

Actualizado: jue., 15 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

Cadian Capital Management LP

9.94%

Morgan Stanley & Co. LLC

9.19%

Brown Capital Management, LLC

8.09%

Millennium Management LLC

6.71%

BlackRock Institutional Trust Company, N.A.

6.49%

Other

59.59%

Accionistas

Proporción

Cadian Capital Management LP

9.94%

Morgan Stanley & Co. LLC

9.19%

Brown Capital Management, LLC

8.09%

Millennium Management LLC

6.71%

BlackRock Institutional Trust Company, N.A.

6.49%

Other

59.59%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

32.08%

Investment Advisor/Hedge Fund

30.11%

Hedge Fund

21.67%

Research Firm

10.87%

Individual Investor

3.48%

Pension Fund

2.50%

Private Equity

1.04%

Sovereign Wealth Fund

0.70%

Bank and Trust

0.34%

Participación institucional

Actualizado: lun., 3 de mar

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q1

397

52.19M

104.12%

-13.96M

2024Q4

407

51.87M

104.93%

-14.28M

2024Q3

422

52.00M

105.24%

-13.61M

2024Q2

423

53.55M

108.72%

-9.95M

2024Q1

437

55.31M

112.51%

-7.56M

2023Q4

468

54.03M

110.37%

-6.18M

2023Q3

482

49.41M

101.04%

-7.52M

2023Q2

492

49.81M

109.19%

-5.40M

2023Q1

500

48.02M

99.15%

-8.43M

2022Q4

513

48.06M

98.07%

-6.28M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Cadian Capital Management LP

4.93M

9.87%

+609.02K

+14.10%

Dec 31, 2024

Morgan Stanley & Co. LLC

4.61M

9.24%

+1.32K

+0.03%

Dec 31, 2024

Brown Capital Management, LLC

4.46M

8.93%

-692.65K

-13.45%

Dec 31, 2024

Millennium Management LLC

4.14M

8.29%

+409.35K

+10.97%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

3.02M

6.06%

-18.57K

-0.61%

Dec 31, 2024

The Vanguard Group, Inc.

2.73M

5.47%

-97.22K

-3.44%

Dec 31, 2024

Fred Alger Management, LLC

2.57M

5.14%

-131.83K

-4.88%

Dec 31, 2024

Natixis Investment Managers SA

1.71M

3.43%

--

Dec 31, 2024

DWS Investments UK Limited

1.40M

2.8%

+12.86K

+0.93%

Dec 31, 2024

New York State Common Retirement Fund

1.15M

2.3%

-37.55K

-3.17%

Dec 31, 2024

ETFs relacionados

Actualizado: vie., 6 de jun

Nombre

Proporción

Invesco NASDAQ Future Gen 200 ETF

0.65%

Inspire Small/Mid Cap ESG ETF

0.21%

JPMorgan Fundamental Data Science Small Core ETF

0.07%

Avantis US Small Cap Equity ETF

0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.03%

Invesco RAFI US 1500 Small-Mid ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

iShares Russell 2000 Growth ETF

0.01%

ProShares Hedge Replication ETF

0.01%

ProShares UltraPro Russell2000

0.01%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.65%

Inspire Small/Mid Cap ESG ETF

Proporción0.21%

JPMorgan Fundamental Data Science Small Core ETF

Proporción0.07%

Avantis US Small Cap Equity ETF

Proporción0.03%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

Proporción0.03%

Invesco RAFI US 1500 Small-Mid ETF

Proporción0.01%

Schwab U.S. Small-Cap ETF

Proporción0.01%

iShares Russell 2000 Growth ETF

Proporción0.01%

ProShares Hedge Replication ETF

Proporción0.01%

ProShares UltraPro Russell2000

Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Cryoport Inc

6.930USD

Cryoport Inc

6.930

Descripción general

Compañía